Frontlight ResearchEarly access
Trial site
Icesp - Instituto Do Câncer Do Estado de São Paulo Octavio Frias de Oliveira
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Metastatic breast cancer4 trials
- Acute myeloid leukaemia2 trials
- Gastric and oesophageal cancer2 trials
- Colorectal cancer1 trial
- Liver and biliary tract cancer1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting7 trials
- Completed4 trials
- Active, not recruiting3 trials
- Lead sponsor
- Daiichi Sankyo6 trials
- BeOne Medicines3 trials
- BeiGene2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- EMD Serono Research & Development Institute, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Gastric and oesophageal cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026